| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 47 |
| 1 | RITONAVIR | 45 |
| 2 | FACTOR IX COMPLEX | 40 |
| 3 | LOPINAVIR AND RITONAVIR | 40 |
| 4 | ANTIHEMOPHILIC FACTOR HUMAN | 39 |
| 5 | TENOFOVIR DISOPROXIL FUMARATE | 38 |
| 6 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 36 |
| 7 | LAMIVUDINE ORAL | 36 |
| 8 | RITUXIMAB | 28 |
| 9 | FLUCONAZOLE | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACONITUM NAPELLUS, BELLADONNA, CHAMOMILLA | 1 | 0.0400 |
| 1 | FACTOR IX COMPLEX | 40 | 0.0342 |
| 2 | ANTIHEMOPHILIC FACTOR HUMAN | 39 | 0.0287 |
| 3 | METHOHEXITAL SODIUM | 1 | 0.0079 |
| 4 | RALTEGRAVIR | 16 | 0.0030 |
| 5 | LOPINAVIR AND RITONAVIR | 40 | 0.0030 |
| 6 | BELINOSTAT | 1 | 0.0028 |
| 7 | MARAVIROC | 6 | 0.0026 |
| 8 | ZIDOVUDINE | 26 | 0.0025 |
| 9 | ABACAVIR SULFATE | 21 | 0.0022 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 6 | 0.0026 |
| 1 | Protease Inhibitor [EPC] | 81 | 0.0018 |
| 2 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 85 | 0.0014 |
| 4 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 31 | 0.0013 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 63 | 0.0013 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 119 | 0.0011 |
| 7 | Antimalarial [EPC] | 6 | 0.0006 |
| 8 | Antiprotozoal [EPC] | 6 | 0.0006 |
| 9 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |